FINWIRES · TerminalLIVE
FINWIRES

Update: Red Cat Plans $200 Million Share Offering; Shares Drop Pre-Bell

By

(Updates with recent stock movement in the headline and the last paragraph)

Red Cat (RCAT) said Tuesday it plans to sell $200 million in shares through an underwritten public offering.

The company also expects to give underwriters a 30-day option to buy up to an additional $30 million in shares at the public offering price, excluding discounts and commissions.

Red Cat said it plans to use the proceeds for general corporate purposes, including acquisitions, business expansion, research and development, capital spending and working capital.

Shares of the company fell more than 10% in recent pre-bell activity Wednesday.

Price: $9.91, Change: $-1.12, Percent Change: -10.15%

Related Articles

Australia

Intuitive Machines Selected for US Space Force Andromeda Contract; Shares Rise Pre-Bell

Intuitive Machines (LUNR) has been selected by the US Space Force and US Space Systems Command for the Andromeda 'indefinite delivery, indefinite quantity' contract, the company said Wednesday in a post on X.Under the contract, the company said it will compete to design and deploy Space Domain Awareness capabilities to detect, track and characterize objects in geosynchronous orbit.Shares of the company were up over 8% in Wednesday premarket trading.Price: $34.85, Change: $+2.76, Percent Change: +8.60%

$LUNR
Australia

Gyre Therapeutics Says China Regulator Accepts Application for Liver Fibrosis Drug

Gyre Therapeutics Inc (GYRE) said China's regulator accepted its new drug application for F351, a treatment for chronic hepatitis B-induced liver fibrosis.The application, which received priority review status in March, marks "a significant milestone" in the program's path toward commercialization, the company said Tuesday in a statement.In the US, Gyre has completed a Phase 1 trial evaluating the drug's safety and tolerability in healthy volunteers and plans to file an investigational new drug application by the end of 2026, with a Phase 2 trial to follow if cleared.Gyre shares rose 1.4% in after-hours trading.

$GYRE
Australia

Evolution Petroleum Swings to Fiscal Q3 Loss as Revenue Falls; Shares Drop After Hours

Evolution Petroleum (EPM) reported a fiscal Q3 adjusted loss late Tuesday of $0.09 per diluted share, swinging from earnings of $0.02 a year earlier.Analysts polled by FactSet expected earnings of $0.02.Revenue in the three months ended March 31 fell to $20.2 million from $22.6 million a year earlier.Analysts surveyed by FactSet expected $21.3 million.Evolution shares fell 7.3% in after-hours trading.

$EPM